JP2025515029A5 - - Google Patents

Info

Publication number
JP2025515029A5
JP2025515029A5 JP2024564653A JP2024564653A JP2025515029A5 JP 2025515029 A5 JP2025515029 A5 JP 2025515029A5 JP 2024564653 A JP2024564653 A JP 2024564653A JP 2024564653 A JP2024564653 A JP 2024564653A JP 2025515029 A5 JP2025515029 A5 JP 2025515029A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
cdr1
cdr2
cdr3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024564653A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025515029A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/066549 external-priority patent/WO2023215787A1/en
Publication of JP2025515029A publication Critical patent/JP2025515029A/ja
Publication of JP2025515029A5 publication Critical patent/JP2025515029A5/ja
Pending legal-status Critical Current

Links

JP2024564653A 2022-05-04 2023-05-03 血管透過性の選択的調節のための組成物及び方法 Pending JP2025515029A (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US202263338359P 2022-05-04 2022-05-04
US63/338,359 2022-05-04
US202363444520P 2023-02-09 2023-02-09
US202363444521P 2023-02-09 2023-02-09
US63/444,520 2023-02-09
US63/444,521 2023-02-09
US202363495763P 2023-04-12 2023-04-12
US202363495765P 2023-04-12 2023-04-12
US63/495,765 2023-04-12
US63/495,763 2023-04-12
PCT/US2023/066549 WO2023215787A1 (en) 2022-05-04 2023-05-03 Compositions and methods for selective regulation of vascular permeability

Publications (2)

Publication Number Publication Date
JP2025515029A JP2025515029A (ja) 2025-05-13
JP2025515029A5 true JP2025515029A5 (cg-RX-API-DMAC7.html) 2026-05-15

Family

ID=88647182

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024564653A Pending JP2025515029A (ja) 2022-05-04 2023-05-03 血管透過性の選択的調節のための組成物及び方法

Country Status (4)

Country Link
US (1) US20250282885A1 (cg-RX-API-DMAC7.html)
EP (1) EP4519320A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025515029A (cg-RX-API-DMAC7.html)
WO (1) WO2023215787A1 (cg-RX-API-DMAC7.html)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017224122B2 (en) * 2016-02-26 2024-04-11 The Board Of Regents Of The University Of Texas System Connexin (Cx) 43 hemichannel-binding antibodies and uses thereof
JP2023537452A (ja) * 2020-05-22 2023-09-01 イエール ユニバーシティ 血管漏出を処置するための方法および組成物
AU2021328375A1 (en) * 2020-08-18 2023-04-13 Cephalon Llc Anti-PAR-2 antibodies and methods of use thereof

Similar Documents

Publication Publication Date Title
JP7852107B2 (ja) 眼科疾患の処置
US12145986B2 (en) Method of treating an ocular condition by administering a humanized monoclonal antibodies that target VE-PTP (HPTP-Beta)
JP7403553B2 (ja) 眼科の疾患の個別化された治療
EA017945B1 (ru) Композиции и способы лечения и профилактики состояний фиброза, воспаления и неоваскуляризации глаза животного
JP7828274B2 (ja) 眼疾患を治療するための方法
AU2020414152B2 (en) Application of fusion protein in treating age-related macular degeneration
KR20220092872A (ko) 당뇨망막병증을 치료하기 위한 방법 및 조성물
JP2021509813A (ja) 持効性かつ低毒性の組替え型の抗vegfヒト化単クローン抗体及びその調製方法
WO2025036488A1 (en) Methods of treating age-related macular degeneration and diabetic macular edema
US20170233467A1 (en) Antibodies Directed to Angiopoietin-1 and Angiopoietin-2 for Ocular Therapies
WO2018195912A1 (zh) 一种眼用药物组合物及其用途
Querques et al. Intravitreal ranibizumab for choroidal neovascularization associated with retinal astrocytic hamartoma
HK40119700A (zh) 眼科疾病的个性化治疗
HK40065038A (en) Personalized treatment of ophthalmologic diseases